COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Lennard Y. W. Lee(University of Birmingham), Jean‐Baptiste Cazier(University of Birmingham), Vasileios Angelis(Royal Marsden Hospital), Roland Arnold(University of Birmingham), Vartika Bisht(University of Birmingham), Naomi Campton, Julia Chackathayil(St George’s University Hospitals NHS Foundation Trust), Vinton W.T. Cheng(University of Leeds), Helen Curley(University of Birmingham), Matthew W. Fittall(Royal Marsden Hospital), Luke Freeman-Mills(Glasgow Royal Infirmary), Spyridon Gennatas(Royal Marsden Hospital), Anshita Goel(University of Birmingham), Simon Hartley(University of Birmingham), D.J. Hughes(King's College London), David Kerr(University of Oxford), Alvin Lee(University College London), Rebecca Lee(University of Manchester), Sophie McGrath(Royal Marsden Hospital), Christopher Middleton(University of Birmingham), Nirupa Murugaesu(St George’s University Hospitals NHS Foundation Trust), Thomas Newsom-Davis(Chelsea and Westminster Hospital NHS Foundation Trust), Alicia Okines(Royal Marsden Hospital), Anna Olsson‐Brown(Clatterbridge Cancer Centre NHS Foundation Trust), Claire Palles(University of Birmingham), Yi Pan(University of Birmingham), Ruth Pettengell(St George's, University of London), Thomas Powles, Emily Protheroe(University of Birmingham), Karin Purshouse(Edinburgh Cancer Research), Archana Sharma‐Oates(University of Birmingham), Shivan Sivakumar(University of Oxford), Ashley J. Smith, Thomas Starkey(University of Birmingham), Chris D. Turnbull(University of Oxford), Csilla Várnai(University of Birmingham), Nadia Yousaf(Royal Marsden Hospital), Rachel Kerr(University of Oxford), Gary Middleton(NIHR Surgical Reconstruction and Microbiology Research Centre)
The Lancet
May 28, 2020
Cited by 1,143Open Access
Full Text

Abstract


Related Papers